医生和患者根据遗传性血管类型报告的结果:来自现实研究的数据
John Anderson1, Daniel Soteres2, Jennifer Mellor3
1From Clinical Research, AllerVie Health, Birmingham, Alabama.
患有正常C1抑制剂遗传性血管 (nC1-INH-HAE) 的患者比患有C1抑制剂缺乏HAE (HAE类型I/II) 的患者更严重的发作和更低的生活质量. 这项现实研究突出了HAE类型之间疾病负担的显著差异.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 流行病学 流行病学
背景情况:
- 遗传性血管 (HAE) 是一种罕见的遗传性疾病,导致严重的发作.
- 关于HAE类型I/II (C1酶抑制剂缺乏/功能障碍) 和正常的C1-INH HAE (nC1-INH-HAE) 之间的结果差异的数据有限.
研究的目的:
- 为了比较HAE类型I/II和nC1-INH-HAE的患者之间的现实结果.
- 评估医生和患者报告的关于疾病活动,严重程度和生活质量的数据.
主要方法:
- 美国医生和HAE患者的横截面调查 (Adelphi HAE疾病特定计划TM) (2021年7月至11月).
- 医生报告了疾病的活动,严重程度和攻击史.
- 患者使用验证的问卷报告了健康状况和生活质量.
主要成果:
- 与HAE类型I/II相比,nC1-INH-HAE患者在诊断和数据收集时显示出更高的疾病活性和严重程度.
- nC1-INH-HAE患者经历了更严重的发作,更高的住院率和更差的生活质量.
- 在nC1-INH-HAE患者 (25%) 和HAE类型I/II (2.7%) 中,缺勤率和工作障碍显著增加.
结论:
- 现实数据表明,nC1-INH-HAE与与HAE类型I/II相比更大的疾病负担有关.
- 患有nC1-INH-HAE的患者面临着日常功能和生活质量受损的增加.
- 需要进一步的统计分析来证实这些发现.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
相关概念视频
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
